Oric Pharmaceuticals (ORIC)

• Market cap: $1.14B
• 1 day: 2.35%
• 5 days: -4.39%
• 1 month: -6.75%
• 3 months: 21.26%
• 6 months: 100.17%
• Year to date: 42.25%
• 1 year: 28.84%
• 5 years: -62.82%
• 10 years: -54.4%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 106